Bloomberg -
22 January 2018, 13:44 (+ 2308 days 4 hours and 46 minutes) Economics
Celgene Corp. agreed to buy Juno Therapeutics Inc. for about $9 billion, one of its largest deals ever, in a bid to expand in the increasingly competitive landscape of cutting-edge cancer treatments.